Neuraxial Trialing Techniques for Spasticity

Michael E. Harned; Jay S. Grider

doi:10.1007/978-3-031-39558-1_35

Neuraxial Trialing Techniques for Spasticity

Michael E. Harned
, Jay S. Grider

Anesthesiology

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Intrathecal baclofen is an effective treatment for the management of patients with spasticity, which is not adequately treated with oral medications. It is best practice to proceed with a trial to assess efficacy as well as tolerability to the therapy prior to implant. There are several scales to document improvement in symptoms, the Modified Ashworth Scale being the most commonly used. Successful trial patients will proceed with implantation of an intrathecal catheter and subcutaneous pump. Once implanted, management of the intrathecal dosing can be performed to match the patient's response and symptom improvement.

Original language	English
Title of host publication	Neuraxial therapeutics
Subtitle of host publication	A comprehensive guide
Pages	699-706
Number of pages	8
ISBN (Electronic)	9783031395581
DOIs	https://doi.org/10.1007/978-3-031-39558-1_35
State	Published - Jan 1 2024

Bibliographical note

Publisher Copyright:
© Springer Nature Switzerland AG 2023.

Keywords

Baclofen
Intrathecal drug delivery
Spasticity

ASJC Scopus subject areas

General Medicine
General Neuroscience

Access to Document

10.1007/978-3-031-39558-1_35

Cite this

@inbook{f8a94cc2b2314fcdb52eadee33b26ddc,

title = "Neuraxial Trialing Techniques for Spasticity",

abstract = "Intrathecal baclofen is an effective treatment for the management of patients with spasticity, which is not adequately treated with oral medications. It is best practice to proceed with a trial to assess efficacy as well as tolerability to the therapy prior to implant. There are several scales to document improvement in symptoms, the Modified Ashworth Scale being the most commonly used. Successful trial patients will proceed with implantation of an intrathecal catheter and subcutaneous pump. Once implanted, management of the intrathecal dosing can be performed to match the patient's response and symptom improvement.",

keywords = "Baclofen, Intrathecal drug delivery, Spasticity",

author = "Harned, \{Michael E.\} and Grider, \{Jay S.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2023.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-3-031-39558-1\_35",

language = "English",

isbn = "9783031395574",

pages = "699--706",

booktitle = "Neuraxial therapeutics",

}

TY - CHAP

T1 - Neuraxial Trialing Techniques for Spasticity

AU - Harned, Michael E.

AU - Grider, Jay S.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2023.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Intrathecal baclofen is an effective treatment for the management of patients with spasticity, which is not adequately treated with oral medications. It is best practice to proceed with a trial to assess efficacy as well as tolerability to the therapy prior to implant. There are several scales to document improvement in symptoms, the Modified Ashworth Scale being the most commonly used. Successful trial patients will proceed with implantation of an intrathecal catheter and subcutaneous pump. Once implanted, management of the intrathecal dosing can be performed to match the patient's response and symptom improvement.

AB - Intrathecal baclofen is an effective treatment for the management of patients with spasticity, which is not adequately treated with oral medications. It is best practice to proceed with a trial to assess efficacy as well as tolerability to the therapy prior to implant. There are several scales to document improvement in symptoms, the Modified Ashworth Scale being the most commonly used. Successful trial patients will proceed with implantation of an intrathecal catheter and subcutaneous pump. Once implanted, management of the intrathecal dosing can be performed to match the patient's response and symptom improvement.

KW - Baclofen

KW - Intrathecal drug delivery

KW - Spasticity

UR - https://www.scopus.com/pages/publications/105008606588

UR - https://www.scopus.com/pages/publications/105008606588#tab=citedBy

U2 - 10.1007/978-3-031-39558-1_35

DO - 10.1007/978-3-031-39558-1_35

M3 - Chapter

AN - SCOPUS:105008606588

SN - 9783031395574

SP - 699

EP - 706

BT - Neuraxial therapeutics

ER -

Neuraxial Trialing Techniques for Spasticity

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this